Literature DB >> 10870580

The release of nitroglycerin absorbed into the central venous catheter.

K Akiyama1, J Hirota, M Takiguchi, S Ohsawa, A Hashimoto.   

Abstract

This study was conducted to evaluate the release of nitroglycerin (NG) that has been absorbed into the central venous catheter. A 0.05% NG solution was infused through a central venous catheter and the flow rates were set at 1, 5, or 10 ml/h, given over 12, 24, or 48 h. The catheter was flushed with lactate Ringer solution after completion of the NG infusion. The elution of the lactate Ringer solution from the tip of the catheter was then collected and assayed for its NG concentration by high performance liquid chromatography (HPLC). A higher concentration of NG was released with a faster flow rate and a longer infusion. The high level of NG release continued during the first 20 min, and ranged from a minimum of 0.07 mg/ml to a maximum that exceeded 0.15 mg/ml. Subsequently, the NG concentration gradually declined, but low concentrations of 0.006-0.02 mg/ml were still maintained 360 min later. Thus, it is suggested that if a catheter such as the Swan-Ganz continues to be used after the completion of a NG infusion, certain pharmacological effects due to the absorption of NG into the catheter body should be expected for at least 60 min.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10870580     DOI: 10.1007/bf02388142

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

1.  Loss of nitroglycerin from plastic intravenous bags.

Authors:  W G Grouthamel; B Dorsch; R Shangraw
Journal:  N Engl J Med       Date:  1978-08-03       Impact factor: 91.245

2.  Effect of vehicle ionic strength on sorption of nitroglycerin to a polyvinyl chloride administration set.

Authors:  S P Loucas; P Maager; B Mehl; E R Loucas
Journal:  Am J Hosp Pharm       Date:  1990-07

3.  The sorption of nitroglycerin by infusion sets.

Authors:  D De Rudder; J P Remon; E N Neyt
Journal:  J Pharm Pharmacol       Date:  1987-07       Impact factor: 3.765

4.  Tolerance to isosorbide dinitrate: rate of development and reversal.

Authors:  J O Parker; H L Fung; D Ruggirello; J A Stone
Journal:  Circulation       Date:  1983-11       Impact factor: 29.690

5.  A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction.

Authors:  J T Flaherty; L C Becker; B H Bulkley; J L Weiss; G Gerstenblith; C H Kallman; K J Silverman; J Y Wei; B Pitt; M L Weisfeldt
Journal:  Circulation       Date:  1983-09       Impact factor: 29.690

6.  Loss of nitroglycerin from intravenous infusion sets.

Authors:  P A Cossum; A J Galbraith; M S Roberts; G W Boyd
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

7.  Nitroglycerin as a hypotensive drug during general anesthesia.

Authors:  N R Fahmy
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

8.  Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets.

Authors:  D M Baaske; A H Amann; D M Wagenknecht; M Mooers; J E Carter; H J Hoyt; R G Stoll
Journal:  Am J Hosp Pharm       Date:  1980-02

Review 9.  Use of nitroglycerin for the treatment of acute myocardial infarction.

Authors:  B I Jugdutt
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

10.  Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy.

Authors:  K Kaplan; R Davison; M Parker; J Przybylek; J R Teagarden; M Lesch
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

View more
  1 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.